Cargando…
Targeting sphingosine-1-phosphate for cancer therapy
This review summarises some important new findings that implicate sphingosine-1-phosphate (S1P) as a potent tumorigenic and angiogenic agent released from cancerous tumours into the tumour microenvironment. Also explored is the novel concept that bioactive lipid signalling molecules, like S1P, can t...
Autor principal: | Sabbadini, R A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360571/ https://www.ncbi.nlm.nih.gov/pubmed/17024123 http://dx.doi.org/10.1038/sj.bjc.6603400 |
Ejemplares similares
-
Ceramide and Sphingosine 1-Phosphate in Liver Diseases
por: Park, Woo-Jae, et al.
Publicado: (2020) -
Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2023) -
Sphingosine-1-Phosphate Transporters as Targets for Cancer Therapy
por: Nagahashi, Masayuki, et al.
Publicado: (2014) -
Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway
por: Gu, Yapeng, et al.
Publicado: (2011) -
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
por: Gupta, Preeti, et al.
Publicado: (2021)